Congenital portosystemic shunts in children: recognition, evaluation, and management

O Bernard1, S Franchi-Abella, S Branchereau

  • 1Hépatologie pédiatrique, Hôpital Bicêtre, AP-HP, Université Paris-Sud, Le Kremlin-Bicêtre, France.

Seminars in Liver Disease
|February 12, 2013
PubMed

Insights

Congenital portosystemic shunts, a rare condition in children, can lead to serious complications. Surgical or radiological closure is often effective, preserving liver function and minimizing the need for transplantation.

Area of Science:

  • Pediatric Surgery
  • Hepatology
  • Vascular Anomalies

Background:

  • Congenital portosystemic shunts (CPSS) affect 1 in 30,000 children.
  • CPSS are associated with severe complications including neonatal cholestasis, liver tumors, hepatopulmonary syndrome, portopulmonary hypertension, and encephalopathy.

Purpose of the Study:

  • To review the diagnosis, management, and outcomes of congenital portosystemic shunts in children.
  • To emphasize the effectiveness of shunt closure and the limited role of liver transplantation.

Main Methods:

  • Review of diagnostic modalities including prenatal ultrasonography, galactosemia screening, and abdominal ultrasound.
  • Discussion of interventional radiology and surgical techniques for shunt closure.
  • Assessment of liver revascularization potential post-closure.

Main Results:

  • Small intrahepatic shunts may spontaneously resolve within the first year of life.
  • Extrahepatic and persistent intrahepatic shunts require closure via interventional radiology or surgery.
  • The liver's portal system demonstrates plasticity, allowing revascularization after shunt closure.

Conclusions:

  • Congenital portosystemic shunts necessitate timely diagnosis and management.
  • Interventional and surgical closure techniques are highly effective, promoting liver revascularization.
  • Liver transplantation is rarely indicated for CPSS due to successful shunt management.

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...